South Korea — Fishery/Seafood Products

← back to leaderboard

South Korea received 35 FDA import refusals in Fishery/Seafood Products between 2023-Q4 and 2026-Q3. Volume peaked at 13 in 2026-Q2, with the trend rising sharply year-on-year. The most-cited issues are mfrhaccp, 807refusal, and salmonella. No trade baseline is published for this commodity from South Korea, so no per-$1B rate is shown here.

Of these, 20 were hazard refusals and 15 were paperwork refusals.

Exporting from South Korea? Get an email when shipments from South Korea are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

2 2023-Q4 2023-Q4: 2 2 2024-Q1 2024-Q1: 2 2 2024-Q2 2024-Q2: 2 1 2024-Q3 2024-Q3: 1 1 2024-Q4 2024-Q4: 1 2 2025-Q1 2025-Q1: 2 0 2025-Q2 2025-Q2: 0 3 2025-Q3 2025-Q3: 3 3 2025-Q4 2025-Q4: 3 4 2026-Q1 2026-Q1: 4 13 2026-Q2 2026-Q2: 13 2 2026-Q3 2026-Q3: 2

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Fish-Other 26 mfrhaccp
Squid-Octopus 9 allergen
Shrimp-Prawn 0

Recent rejections